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A B S T R A C TObjectives: To describe how qualitative methods can be used in the
development of descriptive systems of preference-based measures
(PBMs) of health-related quality of life. Methods: The requirements
of the National Institute for Health and Clinical Excellence and other
agencies together with the increasing use of patient-reported outcome
measures has led to an increase in the demand for PBMs. Recently,
interest has grown in developing new PBMs and while previous
research on PBMs has mainly focused on the methods of valuation,
research into the methods of developing descriptive systems is an
emerging field. Results: Traditionally, descriptive systems of PBMs
were developed by using top-down methods, where content was
derived from existing measures, the literature, or health surveys. A
contrasting approach is a bottom-up methodology, which takes the
views of patients or laypeople on how their life is affected by their
health. This approach generally requires the use of qualitativent matter Copyright & 2012, International Society
r Inc.
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eld, Regent Court, 30 Regent Street, Sheffield S1 4methods. Qualitative methods lend themselves well to the develop-
ment of PBMs. They also ensure that the measure has appropriate
language, content validity, and responsiveness to change. While the
use of qualitative methods in the development of non-PBMs is fairly
standard, their use in developing PBMs was until recently nonexistent.
Conclusions: In this article, we illustrate the use of qualitative meth-
ods by presenting two case studies of recently developed PBMs, one
generic and one condition specific. We outline the stages involved,
discuss the strengths and weaknesses of the approach, and compare
with the top-down approach used in the majority of PBMs to date.
Keywords: outcomes, preference-based measures, QALYs, qualitative
methods.
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There are a large number of health-related quality-of-life
(HRQOL) questionnaires, most of which define the health status
of those completing them in terms of various dimensions such as
mobility or pain. Each of these dimensions typically has a
number of levels that indicate different degrees of severity. These
questionnaires seek to obtain information directly from the
patient and are often referred to as patient-reported outcome
measures or more widely patient-reported outcomes (PROs).
PROs can be used as an umbrella term to cover a range of
potential types of questionnaires that gather self-reported infor-
mation from the patient and include symptom burden, quality of
life (QOL), and HRQOL. In the context of this article, the focus is
only on those aspects of HRQOL that are influenced by health
care interventions and treatments.
The majority of existing HRQOL questionnaires cannot be
used in economic evaluation because they are not preference
based and do not take account of the relative importance of thedifferent dimensions [1]. The need to have HRQOL instruments
that can be used for effectively describing the impact of health
care interventions on patients has been driven by two factors.
The first is the desire to collect data on the quality of care from
the patient’s rather than the clinician’s perspective. The second is
the need to compare interventions, through economic evalua-
tion, to use limited health care resources more efficiently. This
has been formalized in many countries through agencies such as
the National Institute for Health and Clinical Excellence (NICE)
in the United Kingdom [2] and others around the world [3–5].
These decision-making bodies require evidence on the cost-
effectiveness of health care interventions under consideration
as part of the decision-making process. The majority of these
agencies have formal guidelines for the methods of economic
evaluation and while in the past these guidelines have not
stipulated the measure of benefit for cost-effectiveness analysis,
more recently they have explicitly stated that health effects be
measured in quality-adjusted life-years (QALYs) [2,3,5]. In 2004,
NICE introduced its reference case (the set of methods consideredfor Pharmacoeconomics and Outcomes Research (ISPOR).
and Decision Science, School of Health and Related Research,
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benefit. All submissions to NICE now require a cost-effectiveness
analysis based on these methods, with health effects measured
in QALYs [2]. The QALY combines length of life and QOL into a
single summary measure. As well as being able to take account of
changes in HRQOL, quantity of life, or both, it is useful in health
care resource allocation decision making as it allows comparison
across clinical areas because of the use of a common measure of
benefit [1]. QALYs are calculated as the product of the time spent
in a particular health state multiplied by the utility or preference
weight associated with that health state.
There has been an increasing use of data obtained from
non–preference-based PROs within the UK National Health Service
(NHS) stimulated by a key recommendation of the Darzi report,
‘‘High Quality Care for All’’ [6], published under the last Labor
government. This recommended that the impact of treatments
on HRQOL should be measured through the routine use of PROs.
As a result, since 2009, NHS providers have been required to ask
patients to complete a PRO before and after four surgical proce-
dures (hip replacements, knee replacements, hernia repair, and
varicose veins). These data are now published on a monthly basis.
One problem associated with the PROs now routinely used
within the NHS is that they are non–preference-based and scores
from these are calculated by summing the responses for any
domains. However, simply adding up the scores does not provide
information on the relative weights or importance of the different
questions or the different domains because more often than not
each domain is allocated an equal weight [7]. Preference-based
measures (PBMs) are an attempt to take into account the relative
importance of the domains and questions and give an overall
index score that corresponds with the preference-weight compo-
nent of the QALY for a specific health state described by the PRO.
These are based on a scale where 1 is full health and 0 is equi-
valent to being dead (with negative values for health states judged
to be worse than dead). These preference weights for health states
can be obtained in a number of different ways, including the use
of expert opinion, literature, direct valuation from the patient, or
the use of PBMs [1]. A PBM is a type of PRO that typically consists
of a health state classification system (HSCS) and a set of pre-
ference weights for each of the health states defined by the HSCS.
Usually, patients complete the HSCS, which defines their current
health state, and then the preference weight assigned to that
health state can be used to calculate QALYs.Preference-Based Measures
There are two main types of PBMs, generic and condition specific. A
generic PBM is intended to cover all areas of health and should be
applicable to any clinical condition. An example is the EuroQol five-
dimensional (EQ-5D) questionnaire, which has been widely used in
numerous clinical conditions [8]. A condition-specific PBM is con-
cerned only with a particular condition, for example, asthma or
diabetes. It may be used when there are concerns that a generic
PBMmay not be valid or reliable, for example, by not being sensitive
enough. Examples include the Sexual Quality of Life-3D for sexual
QOL [9] and the Asthma Quality of Life-5D for asthma [10]. An
alternative is to develop extra dimensions or ‘‘bolt-ons’’ to fill any
important gaps identified in the coverage of a generic measure [10].
Generic PBMs such as the EQ-5D questionnaire, six-
dimensional health state short form (derived from short form 36
health survey), health utilities index mark 2 (HUI2), and HUI3 have
sometimes been found to be inappropriate or insensitive for some
conditions [1]. Generic measures can sometimes be insensitive to
changes in HRQOL because they do not contain dimensions
important for a specific condition. In these cases, condition-
specific questionnaires may be more appropriate because theyaim to fill in the ‘‘gaps’’ not covered by generic instruments. The
most common method to date to do this has been to modify an
existing condition-specific non-PBM [11]; however, an alternative
is to develop a new measure from scratch where existing
measures have been shown to have poor measurement properties
or have issues with their validation.
In order for non-PBMs to be converted into a PBM, they need to
demonstrate specific properties in terms of their practicality and
ordering of their item scales [1]. The main constraint, however, of
developing a PBM is that the health states defined by the HSCS
should be amenable to valuation. Health state valuation is the way
in which the preference weights for the health states are deter-
mined. It can be undertaken by using a variety of methods,
including standard gamble, time trade-off, or ordinal methods
such as ranking and discrete choice experiments [1]. To be amen-
able to health state valuation, HSCS should have dimensions with
ordinal levels and ideally one item per dimension. In addition,
there is a limit to the number of dimensions that it can contain.
Typically, people can value seven (plus or minus two) pieces of
information at any one time [12], and so the number of dimensions
is typically no more than nine. The most widely used generic
descriptive systems range from five to nine dimensions [1]. This is
a practical constraint on the number of dimensions within a
descriptive system because it is unlikely that respondents would
be able to handle a larger number when undertaking valuation
exercises. Non-PBMs of HRQOL do not have to operate within these
constraints and hence can have much larger descriptive systems.
One example of the limitations of converting existing non-
PBMs has been highlighted in the area of venous leg ulcers. A
review found that there were no existing PBMs, generic PBMs
showed limited sensitivity, and none of the seven condition-
specific non-PBMs were amenable for conversion to PBM [13]. The
reasons for this included that the instruments had limitations in
terms of their practicality, validation, and development.
The requirements of NICE and other agencies together with
the increasing use of PROs in the NHS has led to an increase in
the use of PBMs in health care research and as a consequence, an
increase in the demand for PBMs. In the past, attention has been
focused on the methods of health state valuation and less on the
methods of developing the HSCS. Recently, however, there has
been increasing interest in developing new PBMs, particularly
condition-specific ones [11], and so there is increasing interest in
the methods of development. The objective of this article was to
describe how qualitative methods can be used in the develop-
ment of descriptive systems of PBMs of HRQOL.Methods of Development for PBMs
The main existing generic PBMs for adults have all used a top-
down approach in the development of their descriptive systems;
that is, the content has been derived from existing literature,
instruments, and health surveys. The Measurement and Valua-
tion of Health Survey, which was used to develop the EQ-5D
questionnaire, used 196 members of the general population to
validate five existing descriptive systems by surveying lay con-
cepts [14]. The Quality of Well Being drew its items mainly from
an existing US Health Interview Survey and Social Security
Administration Survey [15], the short form 36 health survey (from
which the six-dimensional health state short form is derived)
used data from existing instruments [16], and the Assessment of
Quality of Life (AQOL) was developed from a literature review
from 1970 and interviews and focus groups with 24 clinicians [17].
The HUI2 was developed from a review of epidemiological
surveys and a review of the literature, which generated a large
pool of potential attributes. A sample of child and parent pairs
then rated these items to select attributes for inclusion. The HUI3
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dimensions to eight (through the separating out of some dimen-
sions and the removal of others) and increasing the number of
levels for all dimensions to between five and six [18].
Three more recently developed generic PBMs for children are
the AQOL-6D [19], the EQ-5DY questionnaire [20], and the Child
Health Utility 9D (CHU9D) [21–23]. Both the AQOL-6D and the EQ-
5DY questionnaire were developed by using top-down methods,
because they have been adapted from the existing adult versions
of their measures (AQOL and the EQ-5D questionnaire, respec-
tively). These top-down adaptations from adult measures risk
missing dimensions pertinent to children and also may include
dimensions that are irrelevant to children. In contrast, the
CHU9D was developed by using bottom-up qualitative methods
and is one of the case studies outlined in this article.
In a recent systematic review of condition-specific PBMs,
Brazier et al. [11] found that just over half (12 out of 22) of
condition-specific PBMs identified were derived from a single
non-PBM for the condition of interest, often using a combination
of factor, psychometric, and Rasch analyses to determine an
HSCS that is amenable to health state valuation. The other 10 had
developed ‘‘de novo’’ classification systems, of which 7 used a
top-down approach of taking items and/or dimensions from
existing questionnaires, the literature, or expert opinion. They
also refined these items/dimensions by using a combination of
psychometric techniques and some limited qualitative research.
The remaining three measures were developed on the basis of
qualitative research. Unfortunately, they provided little detail about
their methodology but tended to interview patients by using semi-
structured or unstructured interviews and then used an expert
panel to select domains and create levels for these domains. None
of these measures were developed to be QALY measures intended
for health care resource allocation; their stated purpose was as a
clinically useful outcome measure. All three followed the same
valuation method and had anchors on the 0 (worst state) and 100
(best state) scale; hence, they were not consistent with the QALY
model of 0 (dead) and 100 (perfect health).
The review by Brazier et al. [11] concluded that the majority of
studies poorly described the methodology used to develop the
measures, particularly the development of their classification
system. This lack of detail contributes to the difficulty of devel-
oping robust methodology in this area. Brazier et al. [11] recom-
mend that further research is needed to examine best practice
and to provide recommendations for the development of
condition-specific PBMs.
A contrasting approach to the top-down methods that have
been described is a bottom-up methodology. This takes the views
of patients or members of the public and seeks their input on
how their HRQOL is affected by their health problem or condition.
This approach generally requires the use of qualitative methods
to generate the items or content of the descriptive system,
through the use of either focus groups or individual interviews
[24]. Examples of non–preference-based instruments that have
taken this approach include the DEMQOL, where both patients
and carers were interviewed to identify items [25], and the
Nottingham Health Profile, which used patients and the general
public [26]. However, it is not uncommon for existing instruments
to have had no input from patients and for there to be an absence
of information in regard to how items were identified [27].
The first application of using a bottom-up methodology with
qualitative methods to develop a measure intended for use in
economic evaluation (although not as a QALY measure) was
undertaken by Grewal et al. [28] in their development of an
HRQOL measure for older people. In this work, they interviewed
people older than 65 years to determine attributes for a new index
focusing on HRQOL for older people. They conducted in-depth
interviews with 40 participants to explore their views about whatwas important to them in terms of HRQOL. From these interview
data they directly developed five conceptual attributes.
This approach of determining attributes or dimensions
directly is in contrast to a common approach historically taken
within the HRQOL instrument development literature [23]. The
standard methodology involved the generation of large lists of
items from interviews, literature, and expert opinion and then a
technique such as factor analysis used to develop the dimen-
sions. This approach has become less common partly through a
wider adoption of qualitative techniques and also the Food and
Drug Administration requirement for the development of PRO
measures [29]. The Food and Drug Administration requires that
measures show evidence that their items have been generated
through taking account of the experience and perspective of the
patient group [30].
The advantages of the bottom-up approach over a top-down
approach are that the final measure developed is likely to have
more appropriate language and terminology for the population,
which should increase the content validity [31]. One benefit could
be an improved responsiveness to change, because it would
include outcomes directly from patients that they feel are
relevant [23]. A further benefit of this bottom-up approach is that
it ties in with initiatives from health care providers such as the
UK NHS, which has a number of initiatives to focus care and
health service research around meeting patient priorities and
inclusion within decision making [32]. In more recent years, the
importance of involving patients and laypeople in the develop-
ment of all types of QOL measures has been more widely
recognized [33] and while the use of qualitative methods in the
development of non-PBMs is now fairly standard, their use in
developing PBMs for use in economic evaluation was until
recently nonexistent.The Use of Qualitative Research
There are a number of critical stages in qualitative research
design [34], the first of which is to review your research question
and decide what type of qualitative data you require. For the
development of PBMs, generated data are usually required, which
are data generated by respondents who give their own inter-
pretation and explanation from interviews, as opposed to natu-
rally occurring data that you may observe in a natural setting.
This is appropriate because you need to generate the data by
asking individuals about how their health affects them; this is
not something that would be naturally occurring and you could
observe as you are trying to collect data on subjective outcomes.
Second, your data unit and time span need to be considered, for
example, case studies of individuals and whether at a point in
time (cross sectional) or over a series of time points. The
development of a PBM most likely demands cross-sectional data
because you are interested in views across the spectrum and not
how people’s views change over time. Third, a data collection
method needs to be determined, for example, focus groups or
individual interviews. Fourth, you need to devise your sampling
strategy, and finally an analytical approach (e.g., thematic con-
tent analysis) needs to be determined, which will largely depend
on the purpose of the research and can be aided with a data
management tool such as NVIVO.
These four stages of qualitative research design can be
applied to the process of developing the descriptive systems of
a PBM. This process can be defined in five stages, and each stage
requires a series of key choices. These stages are summarized
below and then outlined in more detail.1. Identify whom to interview (data unit)
2. Data collection method
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4. Analysis
5. Development of the descriptive systemIdentify Whom to Interview (Data Unit)
First, a decision has to be made about the relevant population(s)
to interview. Perhaps the most relevant population, particularly
for a condition-specific PBM, is the patient population with the
condition, because they have first-hand knowledge about how it
affects their life. Other relevant populations could include carers,
family members, medical professionals, or other experts. One
important reason for focusing on the patient population is that
others can either overestimate or underestimate the impact of a
disease on HRQOL [35]. For example, clinicians tend to focus on
general impacts rather than specific issues related to a disease
and to underestimate the social and subjective aspects of a
disease than do patients [36]. Once the decision regarding whom
to include is made, thought needs to be given to the sampling
frame used. If interviewing patients, they could be sampled
purposively on the basis of their health, so as to include as wide
a range as possible. Other sampling criteria could include age,
gender, and ethnicity to ensure that a wide range of views is
incorporated. For generic measures, identifying whom to inter-
view can be more difficult because you wish to cover as wide a
range of disease areas as possible yet cannot go to the same
breadth of experience within each disease area. There are numer-
ous clinical areas to cover and including only a certain number of
specific clinical groups is likely to bias the measure to the relevant
dimensions for these clinical groups only. Because it is unfeasible
to try and sample from every clinical area, one approach may be
to sample from the general population on the basis of their
general level of health and ensure that as wide a range as possible
is included and saturation is reached. There may be no ideal
sample size for undertaking qualitative data collection, but what
is needed is that the researcher has ensured sufficient breadth in
terms of the data collection to ensure that the sample is
sufficiently large to accurately reflect the impact on HRQOL.
Examples of methods that can be used include member checking,
where the analysis is presented to participants, and triangulation,
where different methods, such as focus groups, are used to
ensure that no new themes are emerging from the data [37].
Data Collection Method
There is a choice to be made between using focus groups,
individual interviews, or a combination of the two. Individual
interviews offer more sensitivity and depth, whereas focus
groups allow participants to feed off each other’s ideas and can
stimulate more discussion. In a focus group, participants can feel
more comfortable; however, if the material being discussed is
sensitive, it may be better to do individual interviews because
they give the opportunity for complete privacy. Focus groups may
lead to inhibitions in raising issues that some may feel are
important, yet others do not and so they are unwilling to share
them. Individual interviews, however, can feel uncomfortable for
shy people and some may feel nervous. Thomas et al. [38] found
that there was no difference in terms of the depth of data
generated between focus groups and interviews. Interviews and
focus groups can also be used to complement each other and
ensure a breadth of data is obtained. For example, focus groups
could provide the initial analysis that can then be explored in
more depth by individual interviews or focus groups could be
used to validate data obtained from interviews [39,40]. For a
generic measure, it may be that a focus group is less suitable,
particularly as individuals are likely to all have different healthconditions, which means that they may prefer to discuss these
on an individual basis and there may be little benefit gained from
the use of a focus group. Ultimately, the choice between these
two methods of data collection needs to be decided with
reference to the population being considered and the practical
advantages and disadvantages of each method [24].
Interview/Focus Group Design
An important consideration for the development of PBMs is
whether to bring existing material to the interview or focus
group, for example, using prompts or suggestions from the
literature or other sources, or to have a blank canvas in terms
of having unstructured interviews. The most commonly used
technique is the use of a semi-structured interview schedule to
direct the interviewee to the subject areas of interest. The level of
structure within qualitative interviews is dependent on the
methodology and underlying epistemology [41], with some pur-
ists arguing that the use of a semi-structured interview cannot be
classified as a qualitative research technique at all due to the
control and direction given by the interviewer [42]. Unstructured
interviews can have the advantage that they allow the intervie-
wees to describe issues that are important to them without the
interviewer assuming control or imposing his or her own agenda.
The advantage of using prompts is that they can help to
stimulate ideas and make use of the existing knowledge base
and evidence. Effective interviewing is a complex skill, and
interviewers need the appropriate training. Unstructured inter-
views can be particularly difficult to conduct and is a skill that
needs practice and reflection [43]. Semi-structured interviews
generally use a topic guide and provide the interviewers with an
interview schedule and prompts in order to direct the intervie-
wees but allow them to explore other areas where appropriate
[44].
Analysis
Before analyzing the data, it is important to check whether data
saturation has been achieved, that is, when no new data are
emerging from the interviews or focus groups [33]. It is important
to achieve saturation for the development of PBMs to make sure
that all areas of HRQOL are captured by the measure.
There are a number of data analysis techniques within
qualitative research, but they all seek to identify and explore
issues and themes reported by the interviewee or focus group
[45]. When analyzing the data, there are two general approaches
that can be taken. First, items can be identified from the inter-
views and then dimensions developed from these, perhaps
through the use of factor or Rasch analysis. This mirrors the
approach taken in the non-PBM literature for instrument devel-
opment [46]. Alternatively, the use of qualitative methods allows
for the identification of dimensions directly from the data, such
as that referred to earlier by Grewal et al. [28].
Development of the Descriptive System
Last, once dimensions have been identified, levels need to be
developed to form an HSCS amenable to valuation. The first
decision is whether the levels should be based on the frequency
or severity of a particular dimension. For example, a dimension
about pain could be either about the frequency of the pain or the
severity of the pain. This choice may depend on the nature of the
condition if developing a condition-specific PBM or may be
related to the purpose of the instrument. Qualitative data could
be used to inform this choice by examining the way in which the
dimensions or items were described in the interview and/or focus
groups. Once this decision is made, wording for the levels needs
to be developed. Existing scales, such as those from existing
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alternative approach would be to develop new ones by using the
qualitative data.Case Studies to Illustrate the Use of Qualitative
Techniques in the Development of PBMs
Recent research by Stevens [21], Palfreyman [47], and Palfreyman
et al. [48] took a bottom-up methodology to the development of
new PBMs by using qualitative methods. We present both of these
as case studies in the context of the key stages outlined above.
The CHU9D is a preference-based generic pediatric HRQOL
measure originally developed for children aged 7 to 11 years
[21] although there is now emerging evidence of its validity in an
adolescent population [49]. The Sheffield Preference-based
Venous Ulcer questionnaire (SPVU-5D) is a condition-specific
preference-based instrument that was developed for use with
venous leg ulceration.
Identify Whom to Interview
For the CHU9D, potential relevant populations to consider
included parents/guardians, pediatric health care professionals,
the general population, health care decision makers, and chil-
dren. All these were considered, and children were chosen as the
population to interview. This was because they were seen as the
most relevant because they were the population the measure was
intended for. By interviewing children, content validity would be
increased [24] and the language and terminology would be more
appropriate than using the views of others. In addition, there is
evidence that parents’ views are affected by their own health
status, knowledge, experience, and expectations [50]. There may
also be areas or contexts of the child’s life that are unknown or
less well known to parents such as school [51]. Drotar [52] also
notes that many children are capable of recognizing and appre-
ciating aspects of their own health, such as symptoms and the
impact of changes in their health, which their parents may not
notice. Children were sampled from the general population via
schools to ensure that as wide a range as possible of health
problems was included while acknowledging that this strategy
would miss those children who were terminally ill or in main
stream schooling [21]. Purposive sampling was used with a
primary criteria of age, followed by level of health (as rated by
the parent on a five-point scale from excellent to poor) to ensure
that the views of a full range of health across the ages were
covered [21]. Secondary criteria were gender and ethnicity.
For the SPVU-5D, both patient and professional perspectives
were sought in developing the instrument. Although patients
were central to the identification of the items for inclusion, it was
felt important to include the views of health professionals. This
was in order to check that no important aspects were omitted
and to further validate the items that were identified by the
patients. A final consideration was that if health professionals
were potentially to use the final instrument they had to be
stakeholders in its development. For patients, purposive sam-
pling was used to ensure that participants recruited approxi-
mated the range of ages, sex, and ethnicity attending the leg
ulcer clinics in Sheffield. Purposive sampling was also used to
ensure that the full range of clinicians involved in the care of
venous ulcer patients was included. The sample included med-
ical and nursing staff from both primary and secondary care
involved in the care.
Both the CHU9D and SPVU-5D instruments used a purposive
sampling approach to include the breadth of experiences of
health of their respective populations. The aim was not to achieve
statistical representativeness, but to capture the experience ofhealth through identifying groups who possessed characteristics
relevant to the health conditions being studied [33].
Data Collection Method
For the CHU9D, in choosing between focus groups and individual
interviews, several considerations pertinent to children were
relevant. The advantage of focus groups is that children can feel
more comfortable and feed off each other’s ideas; however, the
material being discussed was sensitive. In addition, preexisting
dynamics within the groups of children selected can have an
influence on whether children feel comfortable disclosing their
views. Individual interviews give the opportunity for complete
privacy and the opportunity for children to raise any issues that
they wish. Individual interviews were chosen primarily because
of the sensitivity of the topic and also because of the practical-
ities of managing young children in interview/groups situations;
it is easier to manage an individual interview than a focus group
of young children.
For the SPVU-5D, both interviews and focus groups were used
to collect data [47]. The aim was for these to provide different
sources of information and perspectives. One benefit of focus
groups is the added data obtained through the interaction of the
members. Using two different methods of data collection had the
benefit of providing validation of the data interpretation from the
semi-structured interviews and as a means to ensure that data
saturation had been achieved.
Contrasting approaches were taken in developing the two
instruments because of the nature of the populations inter-
viewed and the type of instrument being developed. It would
not have been realistic to expect young children to participate in
focus groups. Another issue was imposed by the nature of the
instruments being developed. The CHUD9D being a generic
measure meant that interviewees may have raised a range of
health problems. However, the SPVU5D was a condition-specific
measure, and so respondents were more likely to feel comfor-
table in a focus group because they all shared the same experi-
ence of one particular health problem/illness.
Interview/Focus Group Design
For the CHU9D, a semi-structured interview format was used,
using a brief topic guide developed from pilot interviews to
ensure that each interview covered the same general questions.
The topic guide included asking the child about his or her health
problems and then about the impact on his or her life, probing to
cover all areas of life (school and at home). The topic guide did
not include any items from the literature or existing instruments
to use as prompts or discussion points because it was felt that
these may have been developed for a different purpose and/or
may not be the views of children and because there is a danger of
acquiescence bias with children, including that preexisting data
may lead or bias the direction of the interview and what the
children think. The aim was therefore for the interviews not to be
influenced by preconceptions about what should be included.
Because this measure was developed with the intention of being
child centered, it was felt that including data from other view-
points would conflict with this.
For the SPVU-5D, a semi-structured interview format was
used but the interview schedule was generated from a review
of the literature that highlighted specific symptoms and areas for
exploration. The issues and areas that arose in earlier interviews,
which gave insights into the impact of venous ulceration on
HRQOL, influenced the focus and discussion of subsequent inter-
views. A number of participants were also reinterviewed and
were presented with the data analysis to check that it was a valid
interpretation of the interviews.
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instruments differed, both techniques can be equally valid. Using
the literature to highlight areas for exploration can have the
benefit of including a wider experience of the health problem and
can also ensure that the final instrument incorporates any
shortcomings of existing measures. The alternative of allowing
the participants to direct the interviews has the advantage of
grounding the instrument more firmly within their experience.
Care has to be taken with this approach to ensure that data
saturation has been reached and that no key areas have been
missed.
Analysis
As the CHU9D was being developed specifically to be a PBM, the
approach to the analysis was to identify dimensions directly from
the data and then to develop levels for each of these because this
suit the structure needed for a PBM. Thematic content analysis
was used because it suits the approach of generating dimensions
from this type of interview data. The analysis was guided by the
research question ‘‘how health affects children’s lives?’’ and the
aim was to identify dimensions of their HRQOL [21].
For the SPVU-5D, a thematic analysis of the data was under-
taken by using Framework analysis techniques [36]. It is particu-
larly suitable for studies within public health and where there are
clear aims at the outset—in this case, identification of items for
inclusion in an HRQOL instrument [53]. The interpretation of the
data was examined through reinterviewing a number of partici-
pants and through using a focus group as the method of
triangulation. This method aimed to ensure that the analysis
had resonance with the experience of venous ulcer patients and
that data saturation had been achieved by ensuring that no
additional issues were highlighted within the focus group.
Both instruments sought to ensure that the qualitative data
were ‘‘trustworthy’’ and ‘‘dependable’’ [54,55]. This aims to
demonstrate that the interpretation of the data was grounded
in the data and not the researcher’s preconceived ideas. The
SPVU-5D included triangulation through the use of a different
data collection technique, and member checking (or respondent
validation) by presenting the analysis to a subgroup of those
interviewed. Triangulation in qualitative research is essentially
the use of different methods and perspectives to move away from
a reliance on a single source of data so as to allow the researcher
to check the breadth of the data collection and verify the
interpretation of the data [33].
Development of the Descriptive System
For the CHU9D, the qualitative data were used to inform whether
the dimensions would be frequency or severity based [22], by
examining the ways in which the children described the dimen-
sions. This has the advantage of ensuring that the resulting
descriptive system accurately reflects how children think about
and describe their HRQOL. This led to the dimensions being
severity based, which also suits a descriptive system with a short
recall period (today/last night), which is desirable for a pediatric
measure [56]. The qualitative data were again used to develop
levels for all the dimensions because there were no suitable
existing scales in the pediatric literature [22]. The advantage of
using the qualitative data in this way is that the terminology of
the children is retained in the measure and the validity and
practicality of the measure should therefore be increased.
For the SPVU-5D, the qualitative data were used to identify
items to be incorporated into the new instrument. For some items,
it was clear from the qualitative interviews that severity and
frequency were an issue. People were concerned with how severe
and frequently pain occurred or how offensive and frequently theirlegs smelled. For other items, it was how often they were able to
undertake a specific activity or the frequency with which a
problem impacted on their HRQOL rather than the severity of the
impact. A choice was made to have five levels within the dimen-
sions to impose a limit on the potential number of health states.
The wording for the levels was based on a review of the current
instruments and intended to not only reflect the same ordering as
the other instruments but also aimed to ensure clear separation
between the item levels. A recall period of 7 days was chosen on
the basis of the treatment regime for venous ulceration, which is
based around compression bandages being usually left in place for
a week. The wording of the questions and the ordering of the levels
of the dimensions were assessed by piloting the questionnaire on a
convenience sample of clinicians and patients.
The development of the descriptive system of both measures
was informed by the qualitative data and the approach to the
analysis. In the case of the CHU9D, this led to dimensions being
developed directly and their type (frequency or severity) and
scales being informed by the qualitative data. In the case of the
SPVU-5D, the qualitative data again informed whether the
dimensions of the instrument should be severity or frequency
based. For some of the items, it was clear from the qualitative
interviews that both severity and frequency were an issue; for
example, people were concerned with how severe and frequently
pain occurred.Discussion
Although both the case studies described above used qualitative
methods in the development of their descriptive systems, they
differed in a number of ways with regard to the choices made at
each stage in the development of the instruments. This was often
dictated by the type of measure and the intended population.
Both measures used a similar approach to sampling to achieve a
breadth of experience. They also used qualitative data to develop
the content of the instrument and to inform the development of
the levels of the HSCS.
For the SPVU-5D condition-specific measure, the use of focus
groups was more likely to increase the richness of the data
collection because of the shared experience of the disease.
Within the focus group, participants can ‘‘feed off’’ each other’s
experience. For the generic measure, the aim was to cover a
range of clinical conditions and so the focus groups would have
been heterogeneous, resulting in a lack of a shared experience.
A bottom-up methodology using qualitative methods offers
several advantages over the traditional top-down approach. By
involving patients and/or lay people, the HSCS will contain
appropriate language and terminology and the dimensions will
be of relevance to the population being studied, ensuring greater
content and face validity. In addition, the measure will be more
patient centered and because it will capture outcomes of rele-
vance to patients, this means it is more likely to be responsive to
change [57]. It should be noted however that it is more likely that
content validity will be increased for a condition-specific measure
because the bottom-up approach allows items to be generated
directly from the patient group and ensuring saturation will mean
that all relevant and appropriate items are included. For a generic
measure, depending on who is interviewed, a wide range of
diseases and conditions is covered and so while taking a
bottom-up methodology will increase content validity over taking
a top-down approach there is still a chance of missing something
important because each different clinical area cannot be covered
in the same depth. This is something that can be tested empiri-
cally by applying the measure in different patient populations.
Taking a bottom-up methodology ensures that the measure
is developed according to its purpose, rather than relying on
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aims and objectives.
Measures developed by using bottom-up methodology are likely
to be more amenable to self-completion by the patient, which is
desirable because it is increasingly recognized in clinical trials and
health services research that descriptions of the experience of a
health state should be elicited from the patients to reflect the actual
experience of the disease and its treatment [58]. Because the
CHU9D was developed by using a bottom-up methodology, it is
much more likely that children will be able to self-complete
because the language and terminology were all determined by
children and subsequent testing of the measure since its develop-
ment has demonstrated that children are easily able to self-
complete it [23,48]. If a child can provide reliable and valid data,
then self-report is the optimal choice [59]. Similarly, the SPVU-5D
should be very amenable to self-completion by the patient.
Qualitative approaches can be used to either generate dimen-
sions directly or to develop a long list of items that then requires
further quantitative work to classify these items into dimensions.
Both of these differing approaches have been illustrated in this
article. The key difference in the approach of generating dimen-
sions directly is that it is perhaps easier to develop a PBM because
it generates one item per dimension and levels within these to
construct an HSCS. This is the ideal for health state valuation. In
contrast, the item generation approach has a stronger use and
reliance on psychometric techniques to develop the dimensions.
Finally, before valuation, it is important that the descriptive
system developed is tested to ensure that it is a valid and reliable
measure [60].Conclusions
In this article we have outlined the value of using qualitative
methods in developing descriptive systems for PBMs used in
economic evaluations. We have described the stages involved
and illustrated these through the use of two case studies.
The recent increase in the number of PBMs means that more
attention needs to be paid to the methods used in their develop-
ment. Particular attention needs to be focused on the develop-
ment of the descriptive systems for PBMs, an area that has
received very little attention in the past. The use of a bottom-
up methodology offers several advantages in this respect over the
use of the more traditional top-down approach used by the
majority of existing PBMs. Content and face validity should be
increased, and the measure will contain more appropriate lan-
guage and terminology. In addition, the dimensions will be of
relevance to the population being studied and the measure will
be more patient centered and amenable to self-completion. Using
this bottom-up methodology means that PBMs can be developed
for purpose rather than having to rely on data from existing
instruments. These may have been developed for other purposes
rather than for use in health care resource allocation decision
making. The use of qualitative techniques means that PBMs will
be more likely to have a valid and reliable descriptive system.
This should be the standard for any PRO, and further research in
this area for PBMs is required.
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